Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PSNL NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePSNLPersonalis$4.88+3.8%$5.88$2.83▼$7.79$416.78M1.861.12 million shs742,397 shsTEMTempus AI$76.30+0.5%$63.98$31.36▼$91.45$13.19B4.9812.26 million shs7.08 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePSNLPersonalis+3.83%+7.73%-24.81%+3.83%-15.86%TEMTempus AI+0.53%+4.41%+18.31%+43.42%+26.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPSNLPersonalis4.1581 of 5 stars3.51.00.04.23.42.50.6TEMTempus AI2.0354 of 5 stars2.33.00.00.03.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePSNLPersonalis 3.00Buy$7.4251.98% UpsideTEMTempus AI 2.50Moderate Buy$67.64-11.35% DownsideCurrent Analyst Ratings BreakdownLatest PSNL and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/20/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$75.00 ➝ $85.008/12/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$65.00 ➝ $68.008/8/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$60.008/8/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral8/8/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.008/6/2025PSNLPersonalisBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$6.008/6/2025PSNLPersonalisHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$9.00 ➝ $8.506/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $70.00(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPSNLPersonalis$84.61M5.11N/AN/A$2.15 per share2.27TEMTempus AI$951.98M13.92N/AN/A$1.78 per share42.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePSNLPersonalis-$81.28M-$1.28N/AN/AN/A-113.70%-47.57%-35.05%11/5/2025 (Estimated)TEMTempus AI-$705.81M-$1.19N/AN/AN/A-20.98%-122.86%-18.09%11/3/2025 (Estimated)Latest PSNL and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025TEMTempus AI-$0.23-$0.22+$0.01-$0.25$296.84 million$314.64 million8/5/2025Q2 2025PSNLPersonalis-$0.25-$0.23+$0.02-$0.23$20.12 million$17.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPSNLPersonalisN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPSNLPersonalisN/A6.095.92TEMTempus AI2.581.541.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPSNLPersonalis61.91%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipPSNLPersonalis3.80%TEMTempus AI26.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePSNLPersonalis40088.68 million85.31 millionOptionableTEMTempus AI2,400173.73 million128.09 millionN/APSNL and TEM HeadlinesRecent News About These CompaniesTempus inks $81M Paige buyout to support AI model developmentAugust 26 at 3:26 PM | finance.yahoo.comTempus AI (NASDAQ:TEM) Stock Price Down 1.8% - What's Next?August 26 at 2:43 PM | marketbeat.comShould Investors Rethink Tempus AI After Shares Double and New Novartis Collaboration?August 26 at 10:26 AM | finance.yahoo.comTempus' Key Acquisitions Strengthen Its AI Healthcare LeadershipAugust 26 at 9:46 AM | zacks.comHsbc Holdings PLC Purchases New Shares in Tempus AI, Inc. $TEMAugust 26 at 4:41 AM | marketbeat.comModerately bullish activity in tempus AI Inc Class A with shares down 1.08%August 25 at 4:11 PM | msn.comTempus AI acquires Paige for $81MAugust 25 at 4:11 PM | mobihealthnews.comMTempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?August 25 at 4:00 PM | zacks.comJump Financial LLC Makes New Investment in Tempus AI, Inc. $TEMAugust 25 at 6:38 AM | marketbeat.comTempus to acquire AI digital pathology company PaigeAugust 25 at 6:10 AM | finance.yahoo.comTD Cowen Lifts Tempus AI (TEM) Price Target on Genomic Volumes GrowthAugust 25 at 2:51 AM | insidermonkey.comTempus AI, Inc. Stock (TEM) Opinions on Recent Earnings and 2025 OutlookAugust 24 at 10:31 AM | quiverquant.comQJasper Ridge Partners L.P. Acquires Shares of 18,134 Tempus AI, Inc. $TEMAugust 24 at 7:13 AM | marketbeat.comEntryPoint Capital LLC Acquires New Position in Tempus AI, Inc. $TEMAugust 24 at 5:07 AM | marketbeat.comCathie Wood Stock Portfolio: Top 10 Stocks to Buy NowAugust 24 at 2:36 AM | insidermonkey.comTempus AI (NASDAQ:TEM) Trading Up 8.9% - What's Next?August 23, 2025 | marketbeat.comPromising Artificial Intelligence Stocks To Research - August 22ndAugust 23, 2025 | marketbeat.comThe Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to ExplodeAugust 23, 2025 | fool.comMichelle Stover SmithAugust 22, 2025 | latimes.comThe Beat: How Chicago's data-center market stacks up to other major hubsAugust 22, 2025 | bizjournals.comInsider Selling: Tempus AI (NASDAQ:TEM) CAO Sells 1,904 Shares of StockAugust 22, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?By Leo Miller | August 13, 2025PSNL and TEM Company DescriptionsPersonalis NASDAQ:PSNL$4.88 +0.18 (+3.83%) Closing price 08/26/2025 04:00 PM EasternExtended Trading$4.82 -0.06 (-1.33%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.Tempus AI NASDAQ:TEM$76.30 +0.40 (+0.53%) Closing price 08/26/2025 04:00 PM EasternExtended Trading$76.38 +0.08 (+0.10%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buffett’s Wisdom Could Spell Trouble for Palantir Shorts Tesla Just Had Its Best Day in 2 Months—Here’s What It Means Reynolds Consumer Products Stock Price: Insiders Signal a Bottom Ubiquiti's 30% Jump: Why This Was a Turnaround, Not Just a Trend How a Superstore Strategy Fueled MINISO’s 20% Stock Surge Petrobras: Why Traders Are Betting Big on a Shareholder Payout Southern Company: From Nuclear Risk to AI Reward BJ’s Wholesale Club Pulls Back to Trend: It’s Time for an Entry Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access